Justification
Xofluza (baloxavir marboxil) 40mg tabs
75A50324F80013-LSJ
Office of Assistant Secretary for Preparedness and Response, Aspr/Orm-Sns. Pharmaceutical Preparation Manufacturing.
Awarded
$0.00 obligated so far on USAspending, September 27, 2024, contract 36F79723D0219
Description
As published on SAM.gov.
Xofluza (baloxavir marboxil) 40mg tablets.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Genentech Usa, Inc.
- UEI
- SA85BMHCTXK5
- CAGE
- 53VP4
- Vendor location
- South San Francisco, CA
- Contract
- 36F79723D0219
- Obligated
- $0.00, potential $4,927,972,430
- Actions
- 58 between February 1, 2024 and July 22, 2026
- Competition
- Full and Open Competition, 999 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- Pharmaceuticals
- Match
- award number 36F79723D0219 equals the contract number; awarding office not confirmed (medium confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
Points of contact
- Terri Reedterri.reed@hhs.gov
Also open from this buyer
- SNS Pharmaceutical Logistic Replenishment RequirementCombined synopsis and solicitationNAICS 325412New York75A50326R00007Closes in 3 daysSep 21